Cargando…

SAT-LB013 The Effect of Select GLP1 Agonists and SGLT2 Inhibitors on the Unfolded Protein Response in Primary Human Coronary Artery Endothelial Cells

Background. GLP1R agonists and SGLT2 inhibitors are classes of medications used in diabetes management. They possess antioxidative properties and inhibit the unfolded protein response (UPR) (endoplasmic reticulum (ER) stress). Since the UPR is involved in atherogenesis, we examined the effects of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalidas, Poonam, Bikkina, Priyanka, Landicho, Marie Angelica, Parekh, Shrina, Haas, Michael, Mooradian, Arshag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Cardiovascular Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552160/ http://dx.doi.org/10.1210/js.2019-SAT-LB013

Ejemplares similares

SUN-LB137 Endocannabinoids Induce Endoplasmic Reticulum Stress in Hepatocytes and Human Coronary Artery Endothelial Cells
por: Richter, Angela, et al.
Publicado: (2020)

Reduced cellular glucose transport confers natural protection against dextrose‐induced superoxide generation and endoplasmic reticulum stress in domestic hen
por: Mooradian, Arshag D., et al.
Publicado: (2021)

SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
por: Rolek, Bartosz, et al.
Publicado: (2023)

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
por: Giugliano, Dario, et al.
Publicado: (2021)

Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
por: Puglisi, Soraya, et al.
Publicado: (2021)

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists
por: Khedagi, Apurva, et al.
Publicado: (2023)

Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults
por: Dadwani, Rahul S., et al.
Publicado: (2023)

MON-289 Pituitary Metastasis: A Systematic Review
por: Parekh, Shrina, et al.
Publicado: (2020)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease
por: Jurado-Flores, Marilu, et al.
Publicado: (2022)

Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
por: Goncalves, Edison, et al.
Publicado: (2018)

SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
por: El Mouhayyar, Christopher, et al.
Publicado: (2020)

Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
por: Winiarska, Agata, et al.
Publicado: (2021)

Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease
por: Georgianos, Panagiotis I., et al.
Publicado: (2022)

Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
por: Cignarelli, Angelo, et al.
Publicado: (2022)

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection
por: Sridhar, Vikas S., et al.
Publicado: (2020)

SAT-LB101 Loss of GLP-2R Signaling Activates Hepatic Stellate Cells and Exacerbates Diet-Induced Steatohepatitis in Mice
por: Fuchs, Shai Z, et al.
Publicado: (2020)

SAT-LB87 Golimumab Induced Thyroiditis
por: Mai, Mo M, et al.
Publicado: (2020)

SAT-LB307 Case of the Broken Hearted
por: Namboodiri, Divya, et al.
Publicado: (2020)

SAT-LB65 A Rare Existence
por: Bedia, Jiselle Aimee Yaplito, et al.
Publicado: (2020)

SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
por: Abdelgadir, Elamin, et al.
Publicado: (2018)

SAT013 Characterization Of CRISPR/Cas9 Induced RXR Isotype Mutants In Xenopus Laevis
por: Furlow, J David, et al.
Publicado: (2023)

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
por: Arnold, Suzanne V., et al.
Publicado: (2022)

Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension
por: King, Nicholas E., et al.
Publicado: (2022)

Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

SUN-LB013 Detecting Resting Adrenal Hyperactivity by Analyzing PR Intervals in Patients with Postural Orthostatic Tachycardia Syndrome
por: Atluri, Ramtej, et al.
Publicado: (2019)

SAT-LB042 Effect of Dehydroepiandrosterone on the Perimenopausal Ovary
por: Luna, Selva, et al.
Publicado: (2019)

SAT-LB83 Amiodarone Induced Myxedema Coma
por: Kim, Keun Young, et al.
Publicado: (2020)

SAT-013 Dihydrotestosterone Does Not Modulate Key Lipogenesis Regulator in Skeletal Muscle from Female Mice
por: Alamgir, Rabita, et al.
Publicado: (2019)

SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
por: Gurgle, Holly E, et al.
Publicado: (2016)

Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
por: Natali, Andrea, et al.
Publicado: (2021)

Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
por: Baviera, Marta, et al.
Publicado: (2022)

Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study
por: Dzaye, Omar, et al.
Publicado: (2022)

PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice
por: Schuetz, Samantha, et al.
Publicado: (2022)

Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence
por: Muller, Dion R. P., et al.
Publicado: (2023)

GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
por: Papaetis, Georgios S.
Publicado: (2023)

SAT-LB083 Pituitary Apoplexy: What a Headache!
por: Perez Garcia, Yanet, et al.
Publicado: (2019)

SAT-LB090 Osteoporosis in Menopausal Women with Autoimmune Thyroiditis
por: Preda, Cristina, et al.
Publicado: (2019)

SAT-LB1 Detection of Serum Macro-Luteinizing Hormone
por: Ogura-Ochi, Kanako, et al.
Publicado: (2020)

SAT-LB43 Allgrove’s: A Syndrome for the “A”ges
por: Bailey, Richard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_19u2sit4t8envujeqcn379djtr